CLVT vs REL.L
CLVT: Clarivate provides critical data, analytics, and workflow solutions that power innovation in the scientific research, intellectual property, and life sciences sectors. REL.L: RELX is a global leader in professional information-based analytics and decision tools, providing critical data insights across the scientific, legal, risk, and events markets.
Side-by-side fundamentals
| Metric | CLVT | REL.L | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $2.13 | £26.49 | |
| Market cap as of 2026-08-06 | $1.4B | n/a | |
| Net margin as of 2026-08-06 | -13.8% | n/a | |
| Gross margin as of 2026-08-06 | +66.8% | n/a | |
| Operating margin as of 2026-08-06 | -3.5% | n/a | |
| ROE as of 2026-08-06 | -7.0% | n/a | |
| ROA as of 2026-08-06 | -3.1% | n/a | |
| Debt / equity as of 2026-08-06 | 0.93 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | -3.5% | n/a | |
| Revenue CAGR (3y) SEC XBRL | -2.6% | n/a | |
| Dividend yield | n/a | n/a | |
| Beta as of 2026-08-06 | 1.37 | n/a | |
| 1-year return as of 2026-07-27 close | -53.0% | -31.9% | REL.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.